Most recent by Michael J. Walsh
Aspirin may not be needed in patients with fully magnetically levitated LVAD
PHILADELPHIA — In patients with advanced HF and a fully magnetically levitated left ventricular assist device, avoiding aspirin was safe and reduced bleeding, researchers reported at the American Heart Association Scientific Sessions.
Lenses an alternative for hyperopia treatment
Surgical treatment of hyperopia has historically been more problematic than treatment of myopia. Surgeons have found that flattening the cornea is easier – and more stable – than steepening it. Some surgeons are concluding that an intraocular approach, whether with phakic or aphakic IOLs, is more reliable than a corneal approach.
Cyclodiode useful treatment in refractory pediatric glaucomas
LONDON – With repeated treatment, cyclodiode can provide control of IOP in refractory pediatric glaucoma. The surgery has a role as a temporizing measure, as an adjunct to surgery or in managing selected patients in whom surgery is undesirable because of a high risk of surgical complications, study authors said.
Ganglion cell death may be caused by vascular damage
OXFORD, England – A new hypothesis on the cause of glaucomatous damage suggests that surgeons should primarily be looking at the back of the eye, where the damage occurs.
Limitations of wavefront becoming apparent, some say
In the past 2 years, excimer laser and ophthalmic diagnostic manufacturers have touted wavefront diagnosis as the coming technology for a golden age of refractive surgery. But will the technology really be all that it has been promoted to be? Some researchers and clinicians are expressing doubt.
I. Howard Fine, MD: teacher, innovator ... biker
With more than 30 years of practice behind him, I. Howard Fine, MD, the engineer turned visionary ophthalmologist, is pleased with his career in ophthalmology.
Some foresee limitations in wavefront technology
In the past 2 years, excimer laser and ophthalmic diagnostic manufacturers have touted wavefront diagnosis as the coming technology for a golden age of refractive surgery. But will the technology really be all that it has been promoted to be? Some researchers and clinicians are expressing doubt.
New CEO in charge of Santen U.S.
NAPA, Calif. — Santen Pharmaceutical announced May 1, the appointment of Adrienne Graves, PhD, president and CEO of its U.S. ophthalmic business.
Cyclodiode useful treatment in refractory pediatric glaucomas
LONDON – With repeated treatment, cyclodiode can provide control of IOP in refractory pediatric glaucoma. The surgery has a role as a temporizing measure, as an adjunct to surgery or in managing selected patients in whom surgery is undesirable because of a high risk of surgical complications, study authors said.
New implants may give presbyopes another option
AURORA, Colo. — The RestorVision Reading implant is showing signs of being an effective surgical treatment for presbyopia in early clinical studies.